Let’s Talk Interactive, Inc. Ranks 50th in Financial Times’ The Americas’ Fastest-Growing Companies in 2023

An innovator in virtual care, LTI is one of the fastest-growing companies in the Americas with a 1,256 percent growth rate between 2018 and 2021.

Let’s Talk Interactive, Inc. (LTI), a leader in customizable virtual care solutions, is ranked number 50 in the Financial Times’ fourth edition of The Americas’ Fastest-Growing Companies, a ranking and special report on high-growth businesses in North, Central, and South America, based on companies with the strongest revenue growth between 2018 and 2021.

“It’s an honor for Let’s Talk Interactive, Inc. to be named among the Financial Times’ fastest-growing companies,” CEO and Founder Art Cooksey said. “This comes on the heels of being recognized by Inc magazine as well, reinforcing our standing as a company that has a high growth potential.”

For this special report, the Financial Times examined over 7,000 public companies across 20 countries. The data was collected via desk research in official sources like publicly available earning presentations, investor relations, websites, and annual reports.

“We continue to innovate in the virtual care sector, one that has experienced challenges and consolidation recently,” Cooksey said. LTI offers healthcare providers a HIPAA-compliant telehealth platform and medical device integrations that increase patient access to quality healthcare.

LTI’s new enterprise telehealth platform, TrustVideo, is customizable with any workflow, can integrate with any EMR/EHR, and serves any medical use case. LTI’s Medcart software pairs with medical hardware such as telemedicine carts, soft packs, and peripherals, which are all part of LTI’s overall custom digital healthcare solutions that enable providers to evaluate patients remotely.

“We are continuing global growth with our partners, AWS, Ingram Micro, Liberty Wesco, and continue to focus on our mission to expand access to healthcare,” Cooksey said. “We are experiencing tremendous growth and look forward to continuing to provide excellent telemedicine solutions to our customers.”

As a leader in creating innovative digital healthcare solutions, the company’s award-winning HIPAA-compliant software is enhanced with custom web and software development as well as provider network solutions that improve access to care at any time, from anywhere in the world.

About Let’s Talk Interactive, Inc.

Let’s Talk Interactive, Inc. is an innovator in telehealth that has developed the most complete and configurable HIPAA-compliant telemedicine platform in the world. Through proprietary telehealth software, medical hardware, and provider network solutions, LTI gives those in need instant access to care. Headquartered in Charlotte, NC, the company ranked No. 496 on the 2022 Inc. 5000 annual list of fastest-growing companies. LTI is committed to providing innovative solutions for patients and healthcare providers in the post-COVID-19 era. For more information about Let’s Talk Interactive, visit www.letstalkinteractive.com.

Contact Information:

Caitlin Wolf

PR and Communications Executive, LTI

[email protected]

980-220-3777

Original Source:

Let’s Talk Interactive, Inc. Ranks 50th in Financial Times’ The Americas’ Fastest-Growing Companies in 2023

Q’Apel Medical Inc. Granted CE Mark Under MDR for Their Walrus Balloon Guide Catheter

Q’Apel Medical Inc. was granted the CE Mark under MDR for Walrus, their U.S. market-leading Balloon Guide Catheter (BGC) utilized in treating patients suffering an acute ischemic stroke. The Walrus BGC has been utilized by Neuro Interventional physicians since 2019 and has successfully treated over 20,000 patients in the United States. 

The Walrus BGC is a unique development in the field of Mechanical Thrombectomy procedures. It provides physicians with not only the known benefits of BGC use clinically, but unique to Walrus, superior ease of use in preparation in these urgent procedures. Importantly, Walrus enables the physicians to navigate the catheter into a more distal location easily and safely compared to other systems, which is associated with improved patient outcomes from stroke.

“The anticipation of Walrus in our international markets has been enormous, and we look forward to the same performance and loyalty around Walrus we have been fortunate to experience in the United States,” said King Nelson, Q’Apel Medical’s CEO.

“We are thrilled to be entering the EU and other international markets with Walrus and providing more physicians in more countries the unparalleled performance of our flagship catheter. This CE Mark certification represents a significant growth milestone for Q’Apel Medical providing access to new markets,” commented Jodie Fam, Chief Marketing Officer & GM International.

About Q’Apel Medical

Q’Apel Medical designs highly innovative technologies for neurovascular interventions and unmet clinical needs. Q’Apel’s portfolio comprises three products, the Walrus Balloon Catheter System, the Wahoo Hybrid Access System and Armadillo Radial Access System. Before Walrus came along, balloon-based variable stiffness catheters brought all manner of technological constraints. Not anymore. By blending flow control, trackability, support, and access into one revolutionary solution, Walrus offers truly unmatched functionality. The Wahoo Hybrid Access System and Armadillo Radial Access System are dual-mode catheters and part of the SelectFlex™ Family of Neurovascular Catheters. These devices feature two distinct operational modes, allowing physicians to easily switch modes at any point during a clinical case and reducing the need for multiple catheters in challenging procedures.

Media Contact: Jodie Fam
415 244 9885

+44 7500702108

[email protected]  
[email protected]
www.qapelmedical.com

Contact Information:

Jodie Fam

Chief Marketing Officer & GM International

[email protected]

4152449885

Original Source:

Q’Apel Medical Inc. Granted CE Mark Under MDR for Their Walrus Balloon Guide Catheter

Caspar’s ChatGPT Integration Empowers Nurses with Interpretable Health Insights

Nurses can access relevant information at their fingertips, enabling faster and more accurate health issue identification

Caspar’s ChatGPT Integration Empowers Nurses with Interpretable Health Insights
Caspar ChatGPT Integration

Caspar ChatGPT Integration

Caspar, the leader in non-intrusive in-home sensing technology, has integrated ChatGPT, an AI-powered conversational platform, to enhance the caregiving experience for nurses and residents.

With ChatGPT’s parsing of information from the Internet, nurses can access relevant information at their fingertips. However, a recent study by Alkaissi and McFarlane[1] highlighted that without proper context, ChatGPT’s output could be misinterpreted or irrelevant.

This is where Caspar comes in. Caspar’s generative AI has access to 24/7 in-home data with which it builds a model for minute-by-minute behavioral predictions about residents, summarized in the form of alerts and observations for nurses and caregivers,” says Corey Gates, VP of Engineering at Caspar. “When linked with ChatGPT’s input layer, pertinent context is provided, enabling faster and more accurate issue identification.”

The system is now available with the Caspar Care App on iOS, Android, and the Web. Using this seamless interface, nurses are providing better care to residents and improving their quality of life. With Caspar, caregivers are detecting issues related to sleep, restlessness, fall, etc. “Physicians and caregivers create interventions based on data and revise care plans,” says Lee Ann Bailey-Clayton, Director of Health Services, The Forest at Duke.

“Caspar is excited to integrate ChatGPT and bring the conversational platform to the forefront of senior caregiving,” says Ashutosh Saxena, CEO and co-founder of Caspar. “We believe that our combined technologies will help caregivers provide the best possible care for residents.”

To learn more about this innovative solution and deploy it in your community, contact Caspar today.

[1] Alkaissi and McFarlane. “Artificial hallucinations in ChatGPT: implications in scientific writing.” Cureus 15.2 (2023).

Contact Information:

Clark Lyons

[email protected]

407-473-3617

Related Files
Caspar_ChatGPT_Integration_SeniorCare.png

Original Source:

Caspar’s ChatGPT Integration Empowers Nurses with Interpretable Health Insights